Breakthrough Genomics
Patrick Mathews has a diverse work experience spanning across various industries. Currently, they work as a Consulting Executive at Sales Leadership Mentoring, where they serve as the Director of Sales for Breakthrough Genomics, a company offering automation software for NGS genomic analysis and diagnostic reporting. In this role, they have developed the value proposition, marketing messaging, and sales processes for the company. Patrick has conducted market analysis and implemented marketing campaigns resulting in 10+ software trials currently underway.
Prior to their current role, Patrick worked at Ataway Ltd as a Business Manager, where they advised the CEO and recommended approaches in areas such as marketing, sales operations, recruiting, and contracting. Patrick also served as the Owner/Principal at Quoin LLC, where they built client relationships with major Media and Entertainment industry leaders and developed a network of expert business domain and technical specialists.
Patrick has also held leadership positions at companies such as Flashline, Inc., Quovadx, Nightfire Software, Supernova, Inc., PSW Technologies, and AGS Information Services. In these roles, they achieved various accomplishments such as expanding client accounts, rebuilding sales teams, planning new vertical market focuses, and launching ASP businesses.
Throughout their career, Patrick has gained extensive experience in sales, business management, marketing, and consulting across a wide range of industries.
Patrick Mathews attended Colgate University, where they pursued a Bachelor of Arts degree in English Language and Literature, General. The duration of their education at Colgate University is unknown.
This person is not in any teams
This person is not in any offices
Breakthrough Genomics
Pioneer in interpreting NGS (WGS, WES and Gene Panel Tests); lab agnostic, yet enabling and fully integrating into turn key solutions. AI/deepML powered proprietary software platform ENLITER™, the most advanced clinical support tool for genomics interpretation. Adapts to a wide variety of pipelines & tests and improves diagnostic yield. Founded by leaders in the genomics field including the Former Clinical Director at Illumina and the former Bioinformatics Director at Quest Diagnostics, Breakthrough Genomics is a pioneer in leveraging machine learning for the analysis of genomic data for clinical purposes. Our proprietary software platform, ENLITERTM mimics the workflow of a U.S. Board-certified medical geneticist and gives healthcare professionals the ability to provide fast turnaround times and improved diagnostic yields for their patients. The ENLITER(TM) platform ranks, prioritizes, and color-codes genetic variants with more accuracy, at a lower cost, and in a fraction of the time compared to the industry clinical standard. ENLITER(TM) also provides additional tools and up-to-date information including a real-time literature presentation for each variant, a powerful free-text phenotype filter, and a detailed copy number and structural variant analysis. ENLITER(TM) works with a wide variety of sequencing data including whole exome, whole genome, gene panels, and SNP array data. ENLITER(TM) is a customizable, secure, cloud-based system that is fully compliant with HIPAA patient data privacy regulations and has received a clinical license for Clinical Genetic Diagnosis. ENLITER(TM) works across a variety of testing categories including, but not limited to, inherited cancer risk, prenatal screening, rare genetic diseases diagnosis, pharmacogenomics, oncology, and other areas such as cardiovascular metabolism. The data produced by ENLITER(TM) gives physicians the ability to more accurately diagnose and treat each individual patient.